Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John L. Musachio is active.

Publication


Featured researches published by John L. Musachio.


Stem Cells | 2007

Persistent Dopamine Functions of Neurons Derived from Embryonic Stem Cells in a Rodent Model of Parkinson Disease

Jose A. Rodríguez‐Gómez; Jian-Qiang Lu; Iván Velasco; Seth N. Rivera; Sami S. Zoghbi; Jeih-San Liow; John L. Musachio; Frederick T. Chin; Hiroshi Toyama; Jurgen Seidel; Michael V. Green; Panayotis K. Thanos; Masanori Ichise; Victor W. Pike; Robert B. Innis; Ron McKay

The derivation of dopamine neurons is one of the best examples of the clinical potential of embryonic stem (ES) cells, but the long‐term function of the grafted neurons has not been established. Here, we show that, after transplantation into an animal model, neurons derived from mouse ES cells survived for over 32 weeks, maintained midbrain markers, and had sustained behavioral effects. Microdialysis in grafted animals showed that dopamine (DA) release was induced by depolarization and pharmacological stimulants. Positron emission tomography measured the expression of presynaptic dopamine transporters in the graft and also showed that the number of postsynaptic DA D2 receptors was normalized in the host striatum. These data suggest that ES cell‐derived neurons show DA release and reuptake and stimulate appropriate postsynaptic responses for long periods after implantation. This work supports continued interest in ES cells as a source of functional DA neurons.


Neuroscience Letters | 2007

PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat

Masao Imaizumi; Hyun-Ju Kim; Sami S. Zoghbi; Emmanuelle Briard; Jinsoo Hong; John L. Musachio; Christl Ruetzler; De-Maw Chuang; Victor W. Pike; Robert B. Innis; Masahiro Fujita

Peripheral benzodiazepine receptors (PBRs) are upregulated on activated microglia. We recently developed a promising positron emission tomography (PET) ligand, [11C]PBR28, with high affinity and excellent ratio of specific to nonspecific binding. We assessed the ability of [11C]PBR28 PET to localize PBRs in a rat permanent middle cerebral artery occlusion (MCAO) model of neuroinflammation. [11C]PBR28 was intravenously administered to rats at 4 and 7 days after permanent MCAO. In all experiments, arterial blood was sampled for compartmental modeling of regional distribution volumes, and rat brains were sampled after imaging for in vitro [3H]PK 11195 autoradiography and histological evaluation. [11C]PBR28 PET and [3H]PK 11195 autoradiography showed similar areas of increased PBRs, especially in the peri-ischemic core. Results from these in vivo and in vitro methods were strongly correlated. In this first study to demonstrate neuroinflammation in vivo with small animal PET, [11C]PBR28 had adequate sensitivity to localize and quantify the associated increase in PBRs.


European Journal of Nuclear Medicine and Molecular Imaging | 2007

Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I

H. Umesha Shetty; Sami S. Zoghbi; Jeih-San Liow; Masanori Ichise; Jinsoo Hong; John L. Musachio; Christer Halldin; Jurgen Seidel; Robert B. Innis; Victor W. Pike

PurposeWe aimed to determine the composition of radioactivity in rat brain after intravenous administration of the dopamine transporter radioligand, [11C]PE2I.MethodsPET time-activity curves (TACs) and regional brain distribution ex vivo were measured using no-carrier-added [11C]PE2I. Carrier-added [11C]PE2I was administered to identify metabolites with high-performance liquid radiochromatography (RC) or RC with mass spectrometry (LC-MS and MS-MS). The stability of [11C]PE2I was assessed in rat brain homogenates.ResultsAfter peak brain uptake of no-carrier-added [11C]PE2I, there was differential washout rate from striata and cerebellum. Thirty minutes after injection, [11C]PE2I represented 10.9 ± 2.9% of the radioactivity in plasma, 67.1 ± 11.0% in cerebellum, and 92.5 ± 3.2% in striata, and was accompanied by two less lipophilic radiometabolites. [11C]PE2I was stable in rat brain homogenate for at least 1 h at 37°C. LC-MS identified hydroxylated PE2I (1) (m/z 442) and carboxyl-desmethyl-PE2I (2) (m/z 456) in brain. MS-MS of 1 gave an m/z 442→424 transition due to H2O elimination, so verifying the presence of a benzyl alcohol group. Metabolite 2 was the benzoic acid derivative. Ratios of ex vivo measurements of [11C]PE2I, [11C]1, and [11C]2 in striata to their cognates in cerebellum were 6.1 ± 3.4, 3.7 ± 2.2 and 1.33 ± 0.38, respectively, showing binding selectivity of metabolite [11C]1 to striata.ConclusionRadiometabolites [11C]1 and [11C]2 were characterized as the 4-hydroxymethyl and 4-carboxyl analogs of [11C]PE2I, respectively. The presence of the pharmacologically active [11C]1 and the inactive [11C]2 is a serious impediment to successful biomathematical analysis.


European Journal of Nuclear Medicine and Molecular Imaging | 2005

PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease

Hiroshi Toyama; Daniel Ye; Masanori Ichise; Jeih-San Liow; Lisheng Cai; David M. Jacobowitz; John L. Musachio; Jinsoo Hong; Mathew Crescenzo; Dnyanesh Tipre; Jian-Qiang Lu; Sami S. Zoghbi; Douglass Vines; Jurgen Seidel; Kazuhiro Katada; Michael V. Green; Victor W. Pike; Robert M. Cohen; Robert B. Innis


Lab on a Chip | 2004

Syntheses of 11C- and 18F-labeled carboxylic esters within a hydrodynamically-driven micro-reactor

Shuiyu Lu; Paul Watts; Frederick T. Chin; Jinsoo Hong; John L. Musachio; Emmanuelle Briard; Victor W. Pike


Synapse | 2007

Kinetic Evaluation in Nonhuman Primates of Two New PET Ligands for Peripheral Benzodiazepine Receptors in Brain

Masao Imaizumi; Emmanuelle Briard; Sami S. Zoghbi; Jonathan P. Gourley; Jinsoo Hong; John L. Musachio; Robert Gladding; Victor W. Pike; Robert B. Innis; Masahiro Fujita


NeuroImage | 2005

Quantification of brain phosphodiesterase 4 in rat with (R)-[11C]Rolipram-PET

Masahiro Fujita; Sami S. Zoghbi; Matthew S. Crescenzo; Jinsoo Hong; John L. Musachio; Jian-Qiang Lu; Jeih-San Liow; Nicholas Seneca; Dnyanesh Tipre; Vanessa Cropley; Masao Imaizumi; Antony D. Gee; Jurgen Seidel; Michael V. Green; Victor W. Pike; Robert B. Innis


Journal of Labelled Compounds and Radiopharmaceuticals | 2007

Integration of a microwave reactor with Synthia to provide a fully automated radiofluorination module

Neva Lazarova; Fabrice G. Siméon; John L. Musachio; Shuiyu Lu; Victor W. Pike


The Journal of Nuclear Medicine | 2006

Whole-Body Biodistribution and Estimation of Radiation-Absorbed Doses of the Dopamine D1 Receptor Radioligand 11C-NNC 112 in Humans

Vanessa Cropley; Masahiro Fujita; John L. Musachio; Jinsoo Hong; Subroto Ghose; Janet Sangare; Pradeep J. Nathan; Victor W. Pike; Robert B. Innis


Synapse | 2007

In vivo and in vitro measurement of brain phosphodiesterase 4 in rats after antidepressant administration

Masahiro Fujita; Masao Imaizumi; Carrol D'Sa; Sami S. Zoghbi; Matthew S. Crescenzo; Jinsoo Hong; John L. Musachio; Antony D. Gee; Jurgen Seidel; Michael V. Green; Victor W. Pike; Ronald S. Duman; Robert B. Innis

Collaboration


Dive into the John L. Musachio's collaboration.

Top Co-Authors

Avatar

Victor W. Pike

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jinsoo Hong

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Robert B. Innis

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Sami S. Zoghbi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Masahiro Fujita

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jeih-San Liow

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jurgen Seidel

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael V. Green

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge